49 research outputs found
Zwischen Immunparalyse und Hyperinflammation: Einflussfaktoren auf die Immunfunktion perioperativ und bei kritisch kranken Patienten
Die Immunfunktion ist für das Outcome perioperativ und von kritisch kranken Patienten entscheidend, eine Immundysfunktion stellt eine eigenständige Organdysfunktion dar. Eine postoperative Immunsuppression ist vor allem mit dem Auftreten von Infektionen und Metastasen assoziiert, während diese bei kritisch kranken Intensivpatienten häufig das Outcome der Sepsis bestimmt. Auch eine überschießende Immunreaktion im Sinne des Hyperinflammationssyndroms HLH kann zum MOV mit Erhöhung der Letalität führen. Eine positive Einflussnahme auf die Immunfunktion, d.h. sowohl die Vermeidung einer Immunsuppression als auch das Erkennen eines Hyperinflammationssyndroms mit Erhalt der Immunhomöostase ist deshalb von herausragender klinischer Relevanz. Die in dieser Habilitationsschrift zusammengefassten Studien untersuchten Einflussfaktoren und Zusammenhänge der Immunfunktion perioperativ und bei kritisch kranken Patienten auf Intensivstationen. Damit soll diese Arbeit dazu beitragen, Patienten bestmöglich zu behandeln und die fatalen Folgen zu verringern. Wir konnten zunächst anhand der durchgeführten Studien zeigen, dass die postoperative Immunkompetenz hauptsächlich durch die Zellen der angeborenen Immunfunktion wiederhergestellt wird. Weiterhin sahen wir in den Ergebnissen, dass Rauchen und Übergewicht die prä- bzw. postoperative Immunfunktion entscheidend schwächen. Intraoperativ stellte sich eine Hyperglykämie als wichtiger Faktor für die postoperative Immunsuppression heraus. Anhand einer RCT konnten wir zeigen, dass die postoperative Gabe von GM-CSF bei immunsupprimierten Patienten die postoperative Immunkompetenz wiederherstellt und die Dauer einer Infektion verringert. Im Rahmen einer Studie zum Hyperinflammationssyndrom HLH fanden wir heraus, dass dieses ebenfalls mit einer hohen Letalität assoziiert ist, jedoch in 78 % aller Fälle nicht diagnostiziert wird. Ein frühzeitiges Erkennen verbessert dabei das Überleben. Die Immunfunktion unterliegt damit Faktoren, die sich positiv beeinflussen lassen und so das Outcome der Patienten verbessern. Das betrifft neben Rauchen, Übergewicht und intraoperativer Hyperglykämie ebenfalls die Möglichkeit der Immunstimulation. Überlebensentscheidend ist vor allem auch das Erkennen eines Hyperinflammationssyndroms
Risk Factors of Intraoperative Dysglycemia in Elderly Surgical Patients
BACKGROUNDː Dysglycemia is associated with adverse outcome including increased morbidity and mortality in surgical patients. Acute insulin resistance due to the surgical stress response is seen as a major cause of so-called stress hyperglycemia. However, understanding of factors determining blood glucose (BG) during surgery is limited. Therefore, we investigated risk factors contributing to intraoperative dysglycemia. METHODSː In this subgroup investigation of the BIOCOG study, we analyzed 87 patients of ≥ 65 years with tight intraoperative BG measurement every 20 min during elective surgery. Dysglycemia was defined as at least one intraoperative BG measurement outside the recommended target range of 80-150 mg/dL. Additionally, all postoperative BG measurements in the ICU were obtained. Multivariable logistic regression analysis adjusted for age, sex, American Society of Anesthesiologists (ASA) status, diabetes, type and duration of surgery, minimum Hemoglobin (Hb) and mean intraoperative norepinephrine use was performed to identify risk factors of intraoperative dysglycemia. RESULTSː 46 (52.9%) out of 87 patients developed intraoperative dysglycemia. 31.8% of all intraoperative BG measurements were detected outside the target range. Diabetes [OR 9.263 (95% CI 2.492, 34.433); p=0.001] and duration of surgery [OR 1.005 (1.000, 1.010); p=0.036] were independently associated with the development of intraoperative dysglycemia. Patients who experienced intraoperative dysglycemia had significantly elevated postoperative mean (p<0.001) and maximum BG levels (p=0.001). Length of ICU (p=0.007) as well as hospital stay (p=0.012) were longer in patients with dysglycemia. CONCLUSIONSː Diabetes and duration of surgery were confirmed as independent risk factors for intraoperative dysglycemia, which was associated with adverse outcome. These patients, therefore, might require intensified glycemic control. Increased awareness and management of intraoperative dysglycemia is warranted
In vivo application of Granulocyte-Macrophage Colony-stimulating Factor enhances postoperative qualitative monocytic function
BACKGROUND: Granulocyte macrophage colony-stimulating factor (GM-CSF) can be
used as a potent stimulator for immune suppressed patients as defined by a
decrease of human leukocyte antigen-D related expression on monocytes (mHLA-
DR) after surgery. However, the exact role of GM-CSF on monocytic and T cell
function is unclear. METHODS: In this retrospective randomized controlled
trial (RCT) subgroup analysis, monocytic respectively T cell function and T
cell subspecies of 20 immune suppressed (i.e. mHLA-DR levels below 10,000
monoclonal antibodies (mAb) per cell at the first day after surgery) patients
after esophageal or pancreatic resection were analyzed. Each 10 patients
received either GM-CSF (250 μg/m²/d) or placebo for a maximum of three
consecutive days if mHLA-DR levels remained below 10,000 mAb per cell. mHLA-DR
and further parameters of immune function were measured preoperatively (od)
until day 5 after surgery (pod5). Statistical analyses were performed using
nonparametric statistical procedures. RESULTS: In multivariate analysis, mHLA-
DR significantly differed between the groups (p < 0.001). mHLA-DR was
increased on pod2 (p < 0.001) and pod3 (p = 0.002) after GM-CSF application.
Tumor necrosis factor-α (TNF-α) release of lipopolysaccharide (LPS) stimulated
monocytes multivariately significantly differed between the groups (p < 0.008)
and was increased in the GM-CSF group on pod2 (p < 0.001) and pod3 (p =
0.046). Th17/regulatory T (Treg) cell ratio was higher after GM-CSF treatment
on pod2 (p = 0.041). No differences were seen in lymphocytes and T helper cell
(Th)1/Th2 specific cytokine production after T cell stimulation with
Concanavalin (Con) A between the groups. CONCLUSIONS: Postoperative
application of GM-CSF significantly enhanced qualitative monocytic function by
increased mHLA-DR and TNF-α release after LPS stimulation and apparently
enhanced Th17/Treg ratio
Smoking, Gender, and Overweight Are Important Influencing Factors on Monocytic HLA-DR before and after Major Cancer Surgery
Background. Monocytic human leukocyte antigen D related (mHLA-DR) is essential
for antigen-presentation. Downregulation of mHLA-DR emerged as a general
biomarker of impaired immunity seen in patients with sepsis and pneumonia and
after major surgery. Influencing factors of mHLA-DR such as age, overweight,
diabetes, smoking, and gender remain unclear. Methods. We analyzed 20 patients
after esophageal or pancreatic resection of a prospective, randomized,
placebo-controlled, double-blind trial (placebo group). mHLA-DR was determined
from day of surgery (od) until postoperative day (pod) 5. Statistical analyses
were performed using multivariate generalized estimating equation analyses
(GEE), nonparametric multivariate analysis of longitudinal data, and
univariate post hoc nonparametric Mann–Whitney tests. Results. In GEE, smoking
and gender were confirmed as significant influencing factors over time.
Univariate analyses of mHLA-DR between smokers and nonsmokers showed lower
preoperative levels () and a trend towards lower levels on pod5 () in smokers.
Lower mHLA-DR was seen in men on pod3 () and on pod5 (). Overweight patients
(BMI > 25 kg/m2) had lower levels of mHLA-DR on pod3 () and pod4 ().
Conclusion. Smoking is an important influencing factor on pre- and
postoperative immune function while postoperative immune function was
influenced by gender and overweight. Clinical trial registered with
ISRCTN27114642
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
This report describes the clinical courses of two acute myeloid leukemia patients. Both had MLL translocations, the first a t(10;11)(p11.2;q23) with MLL-AF10 and the second a t(11;19)(q23;p13.1) with MLL-ELL fusion. They achieved a clinical remission under conventional chemotherapy but relapsed shortly after end of therapy. Both had a history of invasive mycoses (one had possible pulmonary mycosis, one systemic candidiasis). Because no HLA-identical donor was available, a haploidentical transplantation was performed in both cases. Using a specially designed PCR method for the assessment of minimal residual disease (MRD), based on the quantitative detection of the individual chromosomal breakpoint in the MLL gene, all patients achieved complete and persistent molecular remission after transplantation. The immune reconstitution after transplantation is described in terms of total CD3+/CD4+, CD3+/CD8+, CD19+, and CD16+/CD56+ cell numbers over time. The KIR and HLA genotypes of donors and recipients are reported and the possibility of a KIR-mediated alloreactivity is discussed. This report illustrates that haploidentical transplantation may offer a chance of cure without chronic graft-versus-host disease in situations where no suitable HLA-identical donor is available even in a high-risk setting and shows the value of MRD monitoring in the pre- and posttransplant setting
Double Blind, Randomised Controlled Trial
Purpose Surgical patients are at high risk for developing infectious
complications and postoperative delirium. Prolonged infections and delirium
result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-
CSF) and influenza vaccination are known to increase HLA-DR on monocytes and
improve immune reactivity. This study aimed to investigate whether GM-CSF or
vaccination reverses monocyte deactivation. Secondary aims were whether it
decreases infection and delirium days after esophageal or pancreatic resection
over time. Methods In this prospective, randomized, placebo-controlled,
double-blind, double dummy trial setting on an interdisciplinary ICU of a
university hospital 61 patients with immunosuppression (monocytic HLA-DR
[mHLA-DR] <10,000 monoclonal antibodies [mAb] per cell) on the first day after
esophageal or pancreatic resection were treated with either GM-CSF (250
μg/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum
of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on
monocytes was measured daily until day 5 after surgery. Infections and
delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR
on monocytes, and secondary outcomes were duration of infection and delirium.
Results mHLA-DR was significantly increased compared to placebo (p < 0.001)
and influenza vaccination (p < 0.001) on the second postoperative day.
Compared with placebo, GM-CSF-treated patients revealed shorter duration of
infection (p < 0.001); the duration of delirium was increased after
vaccination (p = 0.003). Conclusion Treatment with GM-CSF in patients with
postoperative immune suppression was safe and effective in restoring monocytic
immune competence. Furthermore, therapy with GM-CSF reduced duration of
infection in immune compromised patients. However, influenza vaccination
increased duration of delirium after major surgery
Cerebral microbleeds are not associated with postoperative delirium and postoperative cognitive dysfunction in older individuals
BACKGROUND: Cerebral microbleeds (CMB) occur in the context of cerebral small vessel disease. Other brain MRI markers of cerebral small vessel disease are associated with the occurrence of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD), but for CMB this is unknown. We aimed to study the association between CMB and the occurrence of POD and POCD in older individuals. METHODS: The current study consists of 65 patients (72±5 years) from the BIOCOG study, which is a prospective, observational study of patients who underwent an elective surgery of at least 60 minutes. Patients in the current study received a preoperative cerebral MRI scan including a 3D susceptibility-weighted imaging sequence to detect CMB. The occurrence of POD was screened for twice a day until postoperative day 7 by using the DSM-5, NuDesc, CAM, and CAM-ICU. The occurrence of POCD was determined by the reliable change index model at 7 days after surgery or discharge, respectively, and 3 months after surgery. Statistical analyses consisted of logistic regression adjusted for age and gender. RESULTS: A total of 39 CMB were detected in 17 patients (26%) prior to surgery. POD occurred in 14 out of 65 patients (22%). POCD at 7 days after surgery occurred in 11 out of 54 patients (20%) and in 3 out of 40 patients at the 3 month follow-up (8%). Preoperative CMB were not associated with the occurrence of POD (OR (95%-CI): 0.28 (0.05, 1.57); p = 0.147) or POCD at 7 days after surgery (0.76 (0.16, 3.54); p = 0.727) or at 3 months follow-up (0.61 (0.03, 11.64); p = 0.740). CONCLUSION: We did not find an association between preoperative CMB and the occurrence of POD or POCD. TRIAL REGISTRATION: clinicaltrials.gov (NCT02265263) on 23 September 2014
Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare though often fatal hyperinflammatory syndrome mimicking sepsis in the critically ill. Diagnosis relies on the HLH-2004 criteria and HScore, both of which have been developed in pediatric or adult non-critically ill patients, respectively. Therefore, we aimed to determine the sensitivity and specificity of HLH-2004 criteria and HScore in a cohort of adult critically ill patients.
Methods: In this further analysis of a retrospective observational study, patients ≥ 18 years admitted to at least one adult ICU at Charité - Universitätsmedizin Berlin between January 2006 and August 2018 with hyperferritinemia of ≥ 500 μg/L were included. Patients' charts were reviewed for clinically diagnosed or suspected HLH. Receiver operating characteristics (ROC) analysis was performed to determine prediction accuracy.
Results: In total, 2623 patients with hyperferritinemia were included, of whom 40 patients had HLH. We found the best prediction accuracy of HLH diagnosis for a cutoff of 4 fulfilled HLH-2004 criteria (95.0% sensitivity and 93.6% specificity) and HScore cutoff of 168 (100% sensitivity and 94.1% specificity). By adjusting HLH-2004 criteria cutoffs of both hyperferritinemia to 3000 μg/L and fever to 38.2 °C, sensitivity and specificity increased to 97.5% and 96.1%, respectively. Both a higher number of fulfilled HLH-2004 criteria [OR 1.513 (95% CI 1.372-1.667); p < 0.001] and a higher HScore [OR 1.011 (95% CI 1.009-1.013); p < 0.001] were significantly associated with in-hospital mortality.
Conclusions: An HScore cutoff of 168 revealed a sensitivity of 100% and a specificity of 94.1%, thereby providing slightly superior diagnostic accuracy compared to HLH-2004 criteria. Both HLH-2004 criteria and HScore proved to be of good diagnostic accuracy and consequently might be used for HLH diagnosis in critically ill patients.
Clinical trial registration: The study was registered with www.ClinicalTrials.gov (NCT02854943) on August 1, 2016
Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocol
INTRODUCTION: Haemophagocytic lymphohistiocytosis (HLH) in adults is characterised by toxic immune activation and a sepsis-like syndrome, leading to high numbers of undiagnosed cases and mortality rates of up to 68%. Early diagnosis and specific immune suppressive treatment are mandatory to avoid fatal outcome, but the diagnostic criteria (HLH-2004) are adopted from paediatric HLH and have not been validated in adults. Experimental studies suggest biomarkers to sufficiently diagnose HLH. However, biomarkers for the diagnosis of adult HLH have not yet been investigated.
METHODS AND ANALYSIS: The HEMICU (Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients) study aims to estimate the incidence rate of adult HLH among suspected adult patients in intensive care units (ICUs). Screening for HLH will be performed in 16 ICUs of Charité - Universitätsmedizin Berlin. The inclusion criteria are bicytopaenia, hyperferritinaemia (≥500 µg/L), fever or when HLH is suspected by the clinician. Over a period of 2 years, we expect inclusion of about 100 patients with suspected HLH. HLH will be diagnosed if at least five of the HLH-2004 criteria are fulfilled, together with an expert review; all other included patients will serve as controls. Second, a panel of potential biomarker candidates will be explored. DNA, plasma and serum will be stored in a biobank. The primary endpoint of the study is the incidence rate of adult HLH among suspected adult patients during ICU stay. Out of a variety of measured biomarkers, this study furthermore aims to find highly potential biomarkers for the diagnosis of adult HLH in ICU. The results of this study will contribute to improved recognition and patient outcome of adult HLH in clinical routine
Circadian rhythms in septic shock patients
Background: Despite the intensive efforts to improve the diagnosis and therapy of sepsis over the last decade, the mortality of septic shock remains high and causes substantial socioeconomical burden of disease. The function of immune cells is time-of-day-dependent and is regulated by several circadian clock genes. This study aims to investigate whether the rhythmicity of clock gene expression is altered in patients with septic shock.
Methods: This prospective pilot study was performed at the university hospital Charite-Universitatsmedizin Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK). We included 20 patients with septic shock between May 2014 and January 2018, from whom blood was drawn every 4 h over a 24-h period to isolate CD14-positive monocytes and to measure the expression of 17 clock and clock-associated genes. Of these patients, 3 whose samples expressed fewer than 8 clock genes were excluded from the final analysis. A rhythmicity score S-P was calculated, which comprises values between -1 (arrhythmic) and 1 (rhythmic), and expression data were compared to data of a healthy study population additionally.
Results: 77% of the measured clock genes showed inconclusive rhythms, i.e., neither rhythmic nor arrhythmic. The clock genes NR1D1, NR1D2 and CRY2 were the most rhythmic, while CLOCK and ARNTL were the least rhythmic. Overall, the rhythmicity scores for septic shock patients were significantly (p < 0.0001) lower (0.23 +/- 0.26) compared to the control group (12 healthy young men, 0.70 +/- 0.18). In addition, the expression of clock genes CRY1, NR1D1, NR1D2, DBP, and PER2 was suppressed in septic shock patients and CRY2 was significantly upregulated compared to controls.
Conclusion: Molecular rhythms in immune cells of septic shock patients were substantially altered and decreased compared to healthy young men. The decrease in rhythmicity was clock gene-dependent. The loss of rhythmicity and down-regulation of clock gene expression might be caused by sepsis and might further deteriorate immune responses and organ injury, but further studies are necessary to understand underlying pathophysiological mechanisms